NDC11 43598057901
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 43598-0579-01 | 43598-0579 |
| 43598-0579-1 | 43598-0579 |
| 43598-579-01 | 43598-579 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Dr.Reddys Laboratories Inc | 718756d7-0131-b173-6c45-5ee039b311b0 | 2026-01-12 | Warnings, Adverse reactions | 43598-579-01 43598-579 43598057901 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.